Clinical Trial Update: Safety Study of AMG 557 in Subjects With Lupus Arthritis [Phase 1]

View source ↗

Summary

Phase 1 safety data for AMG 557 in subjects with lupus arthritis and systemic lupus erythematosus has completed enrollment, and the update summarizes the safety…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Arthritis
• Systemic Lupus Erythematosus

Drugs mentioned

• AMG 557

Snippet

Sponsor: Amgen | Conditions: Lupus Arthritis, Systemic Lupus Erythematosus | Phase 1 | Status: COMPLETED